nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—CYP2C19—Gefitinib—lung cancer	0.0719	0.123	CbGbCtD
Guanfacine—CYP2C19—Teniposide—lung cancer	0.0698	0.119	CbGbCtD
Guanfacine—CYP2C9—Gefitinib—lung cancer	0.0598	0.102	CbGbCtD
Guanfacine—CYP2C9—Teniposide—lung cancer	0.058	0.099	CbGbCtD
Guanfacine—CYP3A4—Topotecan—lung cancer	0.038	0.0649	CbGbCtD
Guanfacine—CYP3A4—Gefitinib—lung cancer	0.0348	0.0594	CbGbCtD
Guanfacine—CYP3A4—Teniposide—lung cancer	0.0337	0.0576	CbGbCtD
Guanfacine—CYP2C9—Paclitaxel—lung cancer	0.0324	0.0553	CbGbCtD
Guanfacine—CYP3A4—Vinorelbine—lung cancer	0.0268	0.0457	CbGbCtD
Guanfacine—CYP2C9—Cisplatin—lung cancer	0.026	0.0445	CbGbCtD
Guanfacine—CYP3A4—Crizotinib—lung cancer	0.0213	0.0364	CbGbCtD
Guanfacine—CYP3A4—Erlotinib—lung cancer	0.0206	0.0351	CbGbCtD
Guanfacine—CYP3A4—Paclitaxel—lung cancer	0.0188	0.0321	CbGbCtD
Guanfacine—CYP3A4—Irinotecan—lung cancer	0.0186	0.0317	CbGbCtD
Guanfacine—CYP3A4—Vinblastine—lung cancer	0.0165	0.0282	CbGbCtD
Guanfacine—CYP3A4—Etoposide—lung cancer	0.0149	0.0254	CbGbCtD
Guanfacine—CYP3A4—Docetaxel—lung cancer	0.0136	0.0232	CbGbCtD
Guanfacine—CYP3A4—Doxorubicin—lung cancer	0.0101	0.0173	CbGbCtD
Guanfacine—NISCH—Podofilox—Teniposide—lung cancer	0.00234	0.239	CbGdCrCtD
Guanfacine—NISCH—Paclitaxel—Docetaxel—lung cancer	0.00217	0.222	CbGdCrCtD
Guanfacine—Diclofenac—UGT1A1—lung cancer	0.00178	0.279	CrCbGaD
Guanfacine—Diclofenac—CXCL8—lung cancer	0.00168	0.263	CrCbGaD
Guanfacine—NISCH—Vincristine—Vinorelbine—lung cancer	0.00149	0.152	CbGdCrCtD
Guanfacine—NISCH—Podofilox—Etoposide—lung cancer	0.00139	0.142	CbGdCrCtD
Guanfacine—NISCH—Vinblastine—Vinorelbine—lung cancer	0.0012	0.123	CbGdCrCtD
Guanfacine—NISCH—Vincristine—Vinblastine—lung cancer	0.00119	0.122	CbGdCrCtD
Guanfacine—Diclofenac—CYP2E1—lung cancer	0.000796	0.125	CrCbGaD
Guanfacine—Diclofenac—CYP1A1—lung cancer	0.000785	0.123	CrCbGaD
Guanfacine—Diclofenac—PTGS2—lung cancer	0.000491	0.0768	CrCbGaD
Guanfacine—Diclofenac—ALB—lung cancer	0.000437	0.0684	CrCbGaD
Guanfacine—Diclofenac—ABCB1—lung cancer	0.000417	0.0653	CrCbGaD
Guanfacine—Myalgia—Paclitaxel—lung cancer	0.000277	0.000939	CcSEcCtD
Guanfacine—Arthralgia—Paclitaxel—lung cancer	0.000277	0.000939	CcSEcCtD
Guanfacine—Hypotension—Cisplatin—lung cancer	0.000276	0.000936	CcSEcCtD
Guanfacine—Anxiety—Paclitaxel—lung cancer	0.000276	0.000936	CcSEcCtD
Guanfacine—Decreased appetite—Gemcitabine—lung cancer	0.000276	0.000934	CcSEcCtD
Guanfacine—Nausea—Topotecan—lung cancer	0.000274	0.000929	CcSEcCtD
Guanfacine—Discomfort—Paclitaxel—lung cancer	0.000274	0.000928	CcSEcCtD
Guanfacine—Abdominal discomfort—Methotrexate—lung cancer	0.000274	0.000927	CcSEcCtD
Guanfacine—Fatigue—Gemcitabine—lung cancer	0.000274	0.000927	CcSEcCtD
Guanfacine—Confusional state—Etoposide—lung cancer	0.000273	0.000926	CcSEcCtD
Guanfacine—Constipation—Gemcitabine—lung cancer	0.000271	0.000919	CcSEcCtD
Guanfacine—Nausea—Erlotinib—lung cancer	0.000271	0.000919	CcSEcCtD
Guanfacine—Dry mouth—Paclitaxel—lung cancer	0.000271	0.000918	CcSEcCtD
Guanfacine—Diarrhoea—Vinorelbine—lung cancer	0.00027	0.000915	CcSEcCtD
Guanfacine—Dysgeusia—Docetaxel—lung cancer	0.00027	0.000915	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000269	0.000913	CcSEcCtD
Guanfacine—Feeling abnormal—Irinotecan—lung cancer	0.000268	0.000909	CcSEcCtD
Guanfacine—Confusional state—Paclitaxel—lung cancer	0.000268	0.000907	CcSEcCtD
Guanfacine—Gastrointestinal pain—Irinotecan—lung cancer	0.000266	0.000902	CcSEcCtD
Guanfacine—Oedema—Paclitaxel—lung cancer	0.000266	0.0009	CcSEcCtD
Guanfacine—Paraesthesia—Cisplatin—lung cancer	0.000266	0.0009	CcSEcCtD
Guanfacine—Muscle spasms—Docetaxel—lung cancer	0.000265	0.000899	CcSEcCtD
Guanfacine—Tachycardia—Etoposide—lung cancer	0.000264	0.000896	CcSEcCtD
Guanfacine—Liver function test abnormal—Doxorubicin—lung cancer	0.000264	0.000894	CcSEcCtD
Guanfacine—Dyspnoea—Cisplatin—lung cancer	0.000264	0.000893	CcSEcCtD
Guanfacine—Erectile dysfunction—Methotrexate—lung cancer	0.000263	0.00089	CcSEcCtD
Guanfacine—Hyperhidrosis—Etoposide—lung cancer	0.000262	0.000887	CcSEcCtD
Guanfacine—Feeling abnormal—Gemcitabine—lung cancer	0.000262	0.000886	CcSEcCtD
Guanfacine—Shock—Paclitaxel—lung cancer	0.000261	0.000885	CcSEcCtD
Guanfacine—Dizziness—Vinorelbine—lung cancer	0.000261	0.000885	CcSEcCtD
Guanfacine—Orthostatic hypotension—Doxorubicin—lung cancer	0.000261	0.000885	CcSEcCtD
Guanfacine—Abdominal pain upper—Doxorubicin—lung cancer	0.000261	0.000885	CcSEcCtD
Guanfacine—Tachycardia—Paclitaxel—lung cancer	0.000259	0.000878	CcSEcCtD
Guanfacine—Abdominal pain—Irinotecan—lung cancer	0.000258	0.000872	CcSEcCtD
Guanfacine—Decreased appetite—Cisplatin—lung cancer	0.000257	0.000871	CcSEcCtD
Guanfacine—Hyperhidrosis—Paclitaxel—lung cancer	0.000257	0.00087	CcSEcCtD
Guanfacine—Drowsiness—Methotrexate—lung cancer	0.000254	0.000862	CcSEcCtD
Guanfacine—Hypotension—Etoposide—lung cancer	0.000253	0.000858	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.000252	0.000854	CcSEcCtD
Guanfacine—Vomiting—Vinorelbine—lung cancer	0.000251	0.000851	CcSEcCtD
Guanfacine—Rash—Vinorelbine—lung cancer	0.000249	0.000844	CcSEcCtD
Guanfacine—Dermatitis—Vinorelbine—lung cancer	0.000249	0.000843	CcSEcCtD
Guanfacine—Hypotension—Paclitaxel—lung cancer	0.000248	0.000841	CcSEcCtD
Guanfacine—Headache—Vinorelbine—lung cancer	0.000247	0.000838	CcSEcCtD
Guanfacine—Syncope—Docetaxel—lung cancer	0.000247	0.000838	CcSEcCtD
Guanfacine—Conjunctivitis—Methotrexate—lung cancer	0.000247	0.000838	CcSEcCtD
Guanfacine—Dysphagia—Doxorubicin—lung cancer	0.000247	0.000837	CcSEcCtD
Guanfacine—Asthma—Doxorubicin—lung cancer	0.000247	0.000837	CcSEcCtD
Guanfacine—Sweating—Methotrexate—lung cancer	0.000244	0.000826	CcSEcCtD
Guanfacine—Palpitations—Docetaxel—lung cancer	0.000244	0.000826	CcSEcCtD
Guanfacine—Feeling abnormal—Cisplatin—lung cancer	0.000244	0.000826	CcSEcCtD
Guanfacine—Paraesthesia—Etoposide—lung cancer	0.000243	0.000824	CcSEcCtD
Guanfacine—Loss of consciousness—Docetaxel—lung cancer	0.000243	0.000822	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000242	0.00082	CcSEcCtD
Guanfacine—Dyspnoea—Etoposide—lung cancer	0.000242	0.000818	CcSEcCtD
Guanfacine—Somnolence—Etoposide—lung cancer	0.000241	0.000816	CcSEcCtD
Guanfacine—Insomnia—Paclitaxel—lung cancer	0.00024	0.000814	CcSEcCtD
Guanfacine—Hypersensitivity—Irinotecan—lung cancer	0.00024	0.000813	CcSEcCtD
Guanfacine—Convulsion—Docetaxel—lung cancer	0.000239	0.00081	CcSEcCtD
Guanfacine—Paraesthesia—Paclitaxel—lung cancer	0.000239	0.000808	CcSEcCtD
Guanfacine—Hypertension—Docetaxel—lung cancer	0.000238	0.000807	CcSEcCtD
Guanfacine—Dyspnoea—Paclitaxel—lung cancer	0.000237	0.000802	CcSEcCtD
Guanfacine—Somnolence—Paclitaxel—lung cancer	0.000236	0.0008	CcSEcCtD
Guanfacine—Decreased appetite—Etoposide—lung cancer	0.000236	0.000798	CcSEcCtD
Guanfacine—Chest pain—Docetaxel—lung cancer	0.000235	0.000796	CcSEcCtD
Guanfacine—Arthralgia—Docetaxel—lung cancer	0.000235	0.000796	CcSEcCtD
Guanfacine—Myalgia—Docetaxel—lung cancer	0.000235	0.000796	CcSEcCtD
Guanfacine—Nausea—Vinorelbine—lung cancer	0.000235	0.000795	CcSEcCtD
Guanfacine—Dyspepsia—Paclitaxel—lung cancer	0.000234	0.000792	CcSEcCtD
Guanfacine—Asthenia—Irinotecan—lung cancer	0.000234	0.000792	CcSEcCtD
Guanfacine—Fatigue—Etoposide—lung cancer	0.000234	0.000791	CcSEcCtD
Guanfacine—Constipation—Etoposide—lung cancer	0.000232	0.000785	CcSEcCtD
Guanfacine—Decreased appetite—Paclitaxel—lung cancer	0.000231	0.000782	CcSEcCtD
Guanfacine—Dry mouth—Docetaxel—lung cancer	0.00023	0.000778	CcSEcCtD
Guanfacine—Fatigue—Paclitaxel—lung cancer	0.000229	0.000776	CcSEcCtD
Guanfacine—Pollakiuria—Doxorubicin—lung cancer	0.000228	0.000773	CcSEcCtD
Guanfacine—Asthenia—Gemcitabine—lung cancer	0.000228	0.000771	CcSEcCtD
Guanfacine—Constipation—Paclitaxel—lung cancer	0.000227	0.00077	CcSEcCtD
Guanfacine—Confusional state—Docetaxel—lung cancer	0.000227	0.000769	CcSEcCtD
Guanfacine—Oedema—Docetaxel—lung cancer	0.000225	0.000763	CcSEcCtD
Guanfacine—Weight increased—Doxorubicin—lung cancer	0.000225	0.000762	CcSEcCtD
Guanfacine—Pruritus—Gemcitabine—lung cancer	0.000225	0.000761	CcSEcCtD
Guanfacine—Feeling abnormal—Etoposide—lung cancer	0.000223	0.000756	CcSEcCtD
Guanfacine—Diarrhoea—Irinotecan—lung cancer	0.000223	0.000755	CcSEcCtD
Guanfacine—Gastrointestinal pain—Etoposide—lung cancer	0.000222	0.000751	CcSEcCtD
Guanfacine—Shock—Docetaxel—lung cancer	0.000222	0.000751	CcSEcCtD
Guanfacine—Drowsiness—Doxorubicin—lung cancer	0.00022	0.000746	CcSEcCtD
Guanfacine—Visual impairment—Methotrexate—lung cancer	0.00022	0.000746	CcSEcCtD
Guanfacine—Tachycardia—Docetaxel—lung cancer	0.00022	0.000745	CcSEcCtD
Guanfacine—Feeling abnormal—Paclitaxel—lung cancer	0.000219	0.000742	CcSEcCtD
Guanfacine—Hypersensitivity—Cisplatin—lung cancer	0.000218	0.000738	CcSEcCtD
Guanfacine—Gastrointestinal pain—Paclitaxel—lung cancer	0.000217	0.000736	CcSEcCtD
Guanfacine—Diarrhoea—Gemcitabine—lung cancer	0.000217	0.000735	CcSEcCtD
Guanfacine—Dizziness—Irinotecan—lung cancer	0.000215	0.00073	CcSEcCtD
Guanfacine—Abdominal pain—Etoposide—lung cancer	0.000214	0.000726	CcSEcCtD
Guanfacine—Conjunctivitis—Doxorubicin—lung cancer	0.000214	0.000726	CcSEcCtD
Guanfacine—Eye disorder—Methotrexate—lung cancer	0.000214	0.000723	CcSEcCtD
Guanfacine—Tinnitus—Methotrexate—lung cancer	0.000213	0.000722	CcSEcCtD
Guanfacine—Asthenia—Cisplatin—lung cancer	0.000212	0.000719	CcSEcCtD
Guanfacine—Sweating—Doxorubicin—lung cancer	0.000211	0.000716	CcSEcCtD
Guanfacine—Hypotension—Docetaxel—lung cancer	0.00021	0.000713	CcSEcCtD
Guanfacine—Abdominal pain—Paclitaxel—lung cancer	0.00021	0.000711	CcSEcCtD
Guanfacine—Vomiting—Irinotecan—lung cancer	0.000207	0.000702	CcSEcCtD
Guanfacine—Immune system disorder—Methotrexate—lung cancer	0.000206	0.000699	CcSEcCtD
Guanfacine—Rash—Irinotecan—lung cancer	0.000205	0.000696	CcSEcCtD
Guanfacine—Dermatitis—Irinotecan—lung cancer	0.000205	0.000695	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000205	0.000695	CcSEcCtD
Guanfacine—Headache—Irinotecan—lung cancer	0.000204	0.000691	CcSEcCtD
Guanfacine—Insomnia—Docetaxel—lung cancer	0.000204	0.00069	CcSEcCtD
Guanfacine—Diarrhoea—Cisplatin—lung cancer	0.000202	0.000686	CcSEcCtD
Guanfacine—Paraesthesia—Docetaxel—lung cancer	0.000202	0.000685	CcSEcCtD
Guanfacine—Alopecia—Methotrexate—lung cancer	0.000202	0.000684	CcSEcCtD
Guanfacine—Vomiting—Gemcitabine—lung cancer	0.000202	0.000683	CcSEcCtD
Guanfacine—Bradycardia—Doxorubicin—lung cancer	0.000201	0.000682	CcSEcCtD
Guanfacine—Dyspnoea—Docetaxel—lung cancer	0.000201	0.00068	CcSEcCtD
Guanfacine—Somnolence—Docetaxel—lung cancer	0.0002	0.000678	CcSEcCtD
Guanfacine—Rash—Gemcitabine—lung cancer	0.0002	0.000678	CcSEcCtD
Guanfacine—Dermatitis—Gemcitabine—lung cancer	0.0002	0.000677	CcSEcCtD
Guanfacine—Hypersensitivity—Etoposide—lung cancer	0.0002	0.000676	CcSEcCtD
Guanfacine—Headache—Gemcitabine—lung cancer	0.000199	0.000673	CcSEcCtD
Guanfacine—Rhinitis—Doxorubicin—lung cancer	0.000198	0.000672	CcSEcCtD
Guanfacine—Dyspepsia—Docetaxel—lung cancer	0.000198	0.000671	CcSEcCtD
Guanfacine—Decreased appetite—Docetaxel—lung cancer	0.000196	0.000663	CcSEcCtD
Guanfacine—Hypersensitivity—Paclitaxel—lung cancer	0.000196	0.000663	CcSEcCtD
Guanfacine—Dysgeusia—Methotrexate—lung cancer	0.000195	0.00066	CcSEcCtD
Guanfacine—Asthenia—Etoposide—lung cancer	0.000194	0.000659	CcSEcCtD
Guanfacine—Fatigue—Docetaxel—lung cancer	0.000194	0.000658	CcSEcCtD
Guanfacine—Nausea—Irinotecan—lung cancer	0.000194	0.000655	CcSEcCtD
Guanfacine—Constipation—Docetaxel—lung cancer	0.000193	0.000652	CcSEcCtD
Guanfacine—Pruritus—Etoposide—lung cancer	0.000192	0.000649	CcSEcCtD
Guanfacine—Visual impairment—Doxorubicin—lung cancer	0.000191	0.000646	CcSEcCtD
Guanfacine—Asthenia—Paclitaxel—lung cancer	0.000191	0.000646	CcSEcCtD
Guanfacine—Nausea—Gemcitabine—lung cancer	0.000188	0.000639	CcSEcCtD
Guanfacine—Vomiting—Cisplatin—lung cancer	0.000188	0.000637	CcSEcCtD
Guanfacine—Pruritus—Paclitaxel—lung cancer	0.000188	0.000637	CcSEcCtD
Guanfacine—Vision blurred—Methotrexate—lung cancer	0.000187	0.000635	CcSEcCtD
Guanfacine—Rash—Cisplatin—lung cancer	0.000186	0.000632	CcSEcCtD
Guanfacine—Dermatitis—Cisplatin—lung cancer	0.000186	0.000631	CcSEcCtD
Guanfacine—Feeling abnormal—Docetaxel—lung cancer	0.000186	0.000629	CcSEcCtD
Guanfacine—Diarrhoea—Etoposide—lung cancer	0.000185	0.000628	CcSEcCtD
Guanfacine—Eye disorder—Doxorubicin—lung cancer	0.000185	0.000626	CcSEcCtD
Guanfacine—Ill-defined disorder—Methotrexate—lung cancer	0.000185	0.000625	CcSEcCtD
Guanfacine—Tinnitus—Doxorubicin—lung cancer	0.000184	0.000625	CcSEcCtD
Guanfacine—Gastrointestinal pain—Docetaxel—lung cancer	0.000184	0.000624	CcSEcCtD
Guanfacine—Diarrhoea—Paclitaxel—lung cancer	0.000182	0.000616	CcSEcCtD
Guanfacine—Malaise—Methotrexate—lung cancer	0.000179	0.000608	CcSEcCtD
Guanfacine—Dizziness—Etoposide—lung cancer	0.000179	0.000607	CcSEcCtD
Guanfacine—Immune system disorder—Doxorubicin—lung cancer	0.000179	0.000605	CcSEcCtD
Guanfacine—Vertigo—Methotrexate—lung cancer	0.000179	0.000605	CcSEcCtD
Guanfacine—Abdominal pain—Docetaxel—lung cancer	0.000178	0.000603	CcSEcCtD
Guanfacine—Dizziness—Paclitaxel—lung cancer	0.000176	0.000595	CcSEcCtD
Guanfacine—Nausea—Cisplatin—lung cancer	0.000176	0.000595	CcSEcCtD
Guanfacine—Alopecia—Doxorubicin—lung cancer	0.000175	0.000592	CcSEcCtD
Guanfacine—Convulsion—Methotrexate—lung cancer	0.000172	0.000584	CcSEcCtD
Guanfacine—Vomiting—Etoposide—lung cancer	0.000172	0.000584	CcSEcCtD
Guanfacine—Rash—Etoposide—lung cancer	0.000171	0.000579	CcSEcCtD
Guanfacine—Dermatitis—Etoposide—lung cancer	0.000171	0.000578	CcSEcCtD
Guanfacine—Headache—Etoposide—lung cancer	0.00017	0.000575	CcSEcCtD
Guanfacine—Chest pain—Methotrexate—lung cancer	0.000169	0.000574	CcSEcCtD
Guanfacine—Myalgia—Methotrexate—lung cancer	0.000169	0.000574	CcSEcCtD
Guanfacine—Arthralgia—Methotrexate—lung cancer	0.000169	0.000574	CcSEcCtD
Guanfacine—Tension—Doxorubicin—lung cancer	0.000169	0.000572	CcSEcCtD
Guanfacine—Vomiting—Paclitaxel—lung cancer	0.000169	0.000572	CcSEcCtD
Guanfacine—Dysgeusia—Doxorubicin—lung cancer	0.000169	0.000571	CcSEcCtD
Guanfacine—Rash—Paclitaxel—lung cancer	0.000168	0.000567	CcSEcCtD
Guanfacine—Dermatitis—Paclitaxel—lung cancer	0.000167	0.000567	CcSEcCtD
Guanfacine—Discomfort—Methotrexate—lung cancer	0.000167	0.000567	CcSEcCtD
Guanfacine—Nervousness—Doxorubicin—lung cancer	0.000167	0.000567	CcSEcCtD
Guanfacine—Headache—Paclitaxel—lung cancer	0.000166	0.000564	CcSEcCtD
Guanfacine—Hypersensitivity—Docetaxel—lung cancer	0.000166	0.000562	CcSEcCtD
Guanfacine—Muscle spasms—Doxorubicin—lung cancer	0.000166	0.000561	CcSEcCtD
Guanfacine—Confusional state—Methotrexate—lung cancer	0.000164	0.000554	CcSEcCtD
Guanfacine—Vision blurred—Doxorubicin—lung cancer	0.000162	0.00055	CcSEcCtD
Guanfacine—Asthenia—Docetaxel—lung cancer	0.000162	0.000547	CcSEcCtD
Guanfacine—Nausea—Etoposide—lung cancer	0.000161	0.000545	CcSEcCtD
Guanfacine—Ill-defined disorder—Doxorubicin—lung cancer	0.00016	0.000541	CcSEcCtD
Guanfacine—Pruritus—Docetaxel—lung cancer	0.000159	0.00054	CcSEcCtD
Guanfacine—Agitation—Doxorubicin—lung cancer	0.000158	0.000536	CcSEcCtD
Guanfacine—Nausea—Paclitaxel—lung cancer	0.000158	0.000535	CcSEcCtD
Guanfacine—Hyperhidrosis—Methotrexate—lung cancer	0.000157	0.000532	CcSEcCtD
Guanfacine—Malaise—Doxorubicin—lung cancer	0.000155	0.000526	CcSEcCtD
Guanfacine—Vertigo—Doxorubicin—lung cancer	0.000155	0.000524	CcSEcCtD
Guanfacine—Syncope—Doxorubicin—lung cancer	0.000154	0.000523	CcSEcCtD
Guanfacine—Diarrhoea—Docetaxel—lung cancer	0.000154	0.000522	CcSEcCtD
Guanfacine—Palpitations—Doxorubicin—lung cancer	0.000152	0.000516	CcSEcCtD
Guanfacine—Hypotension—Methotrexate—lung cancer	0.000152	0.000514	CcSEcCtD
Guanfacine—Loss of consciousness—Doxorubicin—lung cancer	0.000151	0.000513	CcSEcCtD
Guanfacine—Convulsion—Doxorubicin—lung cancer	0.000149	0.000505	CcSEcCtD
Guanfacine—Dizziness—Docetaxel—lung cancer	0.000149	0.000504	CcSEcCtD
Guanfacine—Hypertension—Doxorubicin—lung cancer	0.000149	0.000504	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000148	0.000501	CcSEcCtD
Guanfacine—Insomnia—Methotrexate—lung cancer	0.000147	0.000497	CcSEcCtD
Guanfacine—Myalgia—Doxorubicin—lung cancer	0.000147	0.000497	CcSEcCtD
Guanfacine—Chest pain—Doxorubicin—lung cancer	0.000147	0.000497	CcSEcCtD
Guanfacine—Arthralgia—Doxorubicin—lung cancer	0.000147	0.000497	CcSEcCtD
Guanfacine—Anxiety—Doxorubicin—lung cancer	0.000146	0.000495	CcSEcCtD
Guanfacine—Paraesthesia—Methotrexate—lung cancer	0.000146	0.000494	CcSEcCtD
Guanfacine—Discomfort—Doxorubicin—lung cancer	0.000145	0.000491	CcSEcCtD
Guanfacine—Dyspnoea—Methotrexate—lung cancer	0.000145	0.00049	CcSEcCtD
Guanfacine—Somnolence—Methotrexate—lung cancer	0.000144	0.000489	CcSEcCtD
Guanfacine—Dry mouth—Doxorubicin—lung cancer	0.000143	0.000486	CcSEcCtD
Guanfacine—Vomiting—Docetaxel—lung cancer	0.000143	0.000485	CcSEcCtD
Guanfacine—Dyspepsia—Methotrexate—lung cancer	0.000143	0.000484	CcSEcCtD
Guanfacine—Rash—Docetaxel—lung cancer	0.000142	0.000481	CcSEcCtD
Guanfacine—Dermatitis—Docetaxel—lung cancer	0.000142	0.000481	CcSEcCtD
Guanfacine—Confusional state—Doxorubicin—lung cancer	0.000142	0.00048	CcSEcCtD
Guanfacine—Decreased appetite—Methotrexate—lung cancer	0.000141	0.000478	CcSEcCtD
Guanfacine—Headache—Docetaxel—lung cancer	0.000141	0.000478	CcSEcCtD
Guanfacine—Oedema—Doxorubicin—lung cancer	0.000141	0.000476	CcSEcCtD
Guanfacine—Fatigue—Methotrexate—lung cancer	0.00014	0.000474	CcSEcCtD
Guanfacine—Shock—Doxorubicin—lung cancer	0.000138	0.000468	CcSEcCtD
Guanfacine—Tachycardia—Doxorubicin—lung cancer	0.000137	0.000465	CcSEcCtD
Guanfacine—Hyperhidrosis—Doxorubicin—lung cancer	0.000136	0.00046	CcSEcCtD
Guanfacine—Nausea—Docetaxel—lung cancer	0.000134	0.000453	CcSEcCtD
Guanfacine—Feeling abnormal—Methotrexate—lung cancer	0.000134	0.000453	CcSEcCtD
Guanfacine—Gastrointestinal pain—Methotrexate—lung cancer	0.000133	0.00045	CcSEcCtD
Guanfacine—Hypotension—Doxorubicin—lung cancer	0.000131	0.000445	CcSEcCtD
Guanfacine—Abdominal pain—Methotrexate—lung cancer	0.000128	0.000435	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000128	0.000434	CcSEcCtD
Guanfacine—Insomnia—Doxorubicin—lung cancer	0.000127	0.000431	CcSEcCtD
Guanfacine—Paraesthesia—Doxorubicin—lung cancer	0.000126	0.000427	CcSEcCtD
Guanfacine—Dyspnoea—Doxorubicin—lung cancer	0.000125	0.000424	CcSEcCtD
Guanfacine—Somnolence—Doxorubicin—lung cancer	0.000125	0.000423	CcSEcCtD
Guanfacine—Dyspepsia—Doxorubicin—lung cancer	0.000124	0.000419	CcSEcCtD
Guanfacine—Decreased appetite—Doxorubicin—lung cancer	0.000122	0.000414	CcSEcCtD
Guanfacine—Fatigue—Doxorubicin—lung cancer	0.000121	0.00041	CcSEcCtD
Guanfacine—Constipation—Doxorubicin—lung cancer	0.00012	0.000407	CcSEcCtD
Guanfacine—Hypersensitivity—Methotrexate—lung cancer	0.00012	0.000405	CcSEcCtD
Guanfacine—Asthenia—Methotrexate—lung cancer	0.000116	0.000394	CcSEcCtD
Guanfacine—Feeling abnormal—Doxorubicin—lung cancer	0.000116	0.000392	CcSEcCtD
Guanfacine—Gastrointestinal pain—Doxorubicin—lung cancer	0.000115	0.000389	CcSEcCtD
Guanfacine—Pruritus—Methotrexate—lung cancer	0.000115	0.000389	CcSEcCtD
Guanfacine—Abdominal pain—Doxorubicin—lung cancer	0.000111	0.000376	CcSEcCtD
Guanfacine—Diarrhoea—Methotrexate—lung cancer	0.000111	0.000376	CcSEcCtD
Guanfacine—Dizziness—Methotrexate—lung cancer	0.000107	0.000364	CcSEcCtD
Guanfacine—Hypersensitivity—Doxorubicin—lung cancer	0.000104	0.000351	CcSEcCtD
Guanfacine—Vomiting—Methotrexate—lung cancer	0.000103	0.00035	CcSEcCtD
Guanfacine—Rash—Methotrexate—lung cancer	0.000102	0.000347	CcSEcCtD
Guanfacine—Dermatitis—Methotrexate—lung cancer	0.000102	0.000346	CcSEcCtD
Guanfacine—Headache—Methotrexate—lung cancer	0.000102	0.000344	CcSEcCtD
Guanfacine—Asthenia—Doxorubicin—lung cancer	0.000101	0.000342	CcSEcCtD
Guanfacine—Pruritus—Doxorubicin—lung cancer	9.94e-05	0.000337	CcSEcCtD
Guanfacine—Nausea—Methotrexate—lung cancer	9.64e-05	0.000327	CcSEcCtD
Guanfacine—Diarrhoea—Doxorubicin—lung cancer	9.62e-05	0.000326	CcSEcCtD
Guanfacine—Dizziness—Doxorubicin—lung cancer	9.29e-05	0.000315	CcSEcCtD
Guanfacine—Vomiting—Doxorubicin—lung cancer	8.94e-05	0.000303	CcSEcCtD
Guanfacine—Rash—Doxorubicin—lung cancer	8.86e-05	0.0003	CcSEcCtD
Guanfacine—Dermatitis—Doxorubicin—lung cancer	8.85e-05	0.0003	CcSEcCtD
Guanfacine—Headache—Doxorubicin—lung cancer	8.8e-05	0.000298	CcSEcCtD
Guanfacine—Nausea—Doxorubicin—lung cancer	8.35e-05	0.000283	CcSEcCtD
Guanfacine—ADRA2A—GPCR downstream signaling—PIK3CD—lung cancer	1.84e-05	0.000179	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—RRM1—lung cancer	1.83e-05	0.000178	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GSTA3—lung cancer	1.83e-05	0.000178	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GSTT1—lung cancer	1.83e-05	0.000178	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—ERBB3—lung cancer	1.83e-05	0.000178	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—TYMS—lung cancer	1.83e-05	0.000178	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP2A6—lung cancer	1.81e-05	0.000176	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GCLC—lung cancer	1.81e-05	0.000176	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—POMC—lung cancer	1.81e-05	0.000176	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—GSTM1—lung cancer	1.81e-05	0.000176	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.81e-05	0.000176	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—STK11—lung cancer	1.78e-05	0.000173	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—IL6R—lung cancer	1.76e-05	0.000172	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—IL2—lung cancer	1.76e-05	0.000171	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TERT—lung cancer	1.76e-05	0.000171	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—B4GALT5—lung cancer	1.72e-05	0.000168	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ENO1—lung cancer	1.72e-05	0.000167	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FOXO3—lung cancer	1.72e-05	0.000167	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CYP1A1—lung cancer	1.71e-05	0.000167	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.71e-05	0.000166	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—FGFR1—lung cancer	1.7e-05	0.000166	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ERCC2—lung cancer	1.7e-05	0.000165	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP2E1—lung cancer	1.69e-05	0.000164	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.69e-05	0.000164	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—KRAS—lung cancer	1.68e-05	0.000164	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—MAP2K1—lung cancer	1.68e-05	0.000163	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—HIF1A—lung cancer	1.68e-05	0.000163	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GSTA4—lung cancer	1.68e-05	0.000163	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—NQO1—lung cancer	1.67e-05	0.000162	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PIK3CD—lung cancer	1.67e-05	0.000162	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—AKT1—lung cancer	1.67e-05	0.000162	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.64e-05	0.000159	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GSTA2—lung cancer	1.63e-05	0.000159	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.62e-05	0.000158	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—APOA1—lung cancer	1.62e-05	0.000158	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AVP—lung cancer	1.61e-05	0.000156	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—KDR—lung cancer	1.61e-05	0.000156	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—PIK3CB—lung cancer	1.6e-05	0.000156	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GSTA1—lung cancer	1.58e-05	0.000153	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ABCC3—lung cancer	1.56e-05	0.000152	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IGF1R—lung cancer	1.55e-05	0.00015	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—PIK3CA—lung cancer	1.55e-05	0.00015	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP2E1—lung cancer	1.54e-05	0.00015	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—CXCL8—lung cancer	1.54e-05	0.00015	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—NQO1—lung cancer	1.52e-05	0.000148	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HES1—lung cancer	1.52e-05	0.000148	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—AKR1C1—lung cancer	1.51e-05	0.000147	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—STK11—lung cancer	1.51e-05	0.000146	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—TP53—lung cancer	1.5e-05	0.000145	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.49e-05	0.000145	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—RAF1—lung cancer	1.49e-05	0.000145	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3CG—lung cancer	1.48e-05	0.000144	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—APC—lung cancer	1.48e-05	0.000144	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—KIT—lung cancer	1.48e-05	0.000144	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—NRAS—lung cancer	1.48e-05	0.000144	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.48e-05	0.000144	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—IL2—lung cancer	1.47e-05	0.000143	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—APOA1—lung cancer	1.47e-05	0.000143	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—UGT1A1—lung cancer	1.47e-05	0.000143	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—EGF—lung cancer	1.46e-05	0.000142	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PIK3CB—lung cancer	1.46e-05	0.000142	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—HRAS—lung cancer	1.43e-05	0.000139	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—MAPK3—lung cancer	1.42e-05	0.000138	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.41e-05	0.000137	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GNG11—lung cancer	1.41e-05	0.000137	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—POMC—lung cancer	1.41e-05	0.000137	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CXCL8—lung cancer	1.4e-05	0.000136	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GSTP1—lung cancer	1.39e-05	0.000135	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—BRAF—lung cancer	1.39e-05	0.000135	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ERBB3—lung cancer	1.39e-05	0.000135	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IL6R—lung cancer	1.37e-05	0.000134	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—STK11—lung cancer	1.37e-05	0.000134	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CREBBP—lung cancer	1.37e-05	0.000133	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CAT—lung cancer	1.36e-05	0.000132	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.35e-05	0.000131	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—EGFR—lung cancer	1.35e-05	0.000131	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALDOA—lung cancer	1.35e-05	0.000131	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3CG—lung cancer	1.34e-05	0.000131	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—IL2—lung cancer	1.34e-05	0.00013	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TERT—lung cancer	1.33e-05	0.00013	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ABCB1—lung cancer	1.32e-05	0.000128	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MAP2K1—lung cancer	1.31e-05	0.000127	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NCOA3—lung cancer	1.31e-05	0.000127	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3CD—lung cancer	1.3e-05	0.000126	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—TYMS—lung cancer	1.3e-05	0.000126	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FGFR1—lung cancer	1.29e-05	0.000126	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.29e-05	0.000125	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—PIK3CA—lung cancer	1.29e-05	0.000125	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GSTM1—lung cancer	1.28e-05	0.000125	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—POMC—lung cancer	1.28e-05	0.000124	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HIF1A—lung cancer	1.27e-05	0.000124	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—KRAS—lung cancer	1.27e-05	0.000124	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ABCG2—lung cancer	1.27e-05	0.000124	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ADCY1—lung cancer	1.27e-05	0.000124	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GSTP1—lung cancer	1.27e-05	0.000124	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—AKT1—lung cancer	1.26e-05	0.000123	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ENO2—lung cancer	1.25e-05	0.000121	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HPGDS—lung cancer	1.25e-05	0.000121	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CREBBP—lung cancer	1.24e-05	0.000121	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.24e-05	0.00012	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CAT—lung cancer	1.24e-05	0.00012	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.23e-05	0.00012	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APOA1—lung cancer	1.23e-05	0.00012	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—KDR—lung cancer	1.22e-05	0.000118	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP1A1—lung cancer	1.21e-05	0.000118	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GSTT1—lung cancer	1.21e-05	0.000118	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ERCC2—lung cancer	1.2e-05	0.000117	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ABCB1—lung cancer	1.2e-05	0.000117	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP2A6—lung cancer	1.2e-05	0.000116	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GCLC—lung cancer	1.2e-05	0.000116	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—TYMS—lung cancer	1.18e-05	0.000115	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3CD—lung cancer	1.18e-05	0.000115	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—PIK3CA—lung cancer	1.17e-05	0.000114	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GSTM1—lung cancer	1.17e-05	0.000114	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MDM2—lung cancer	1.17e-05	0.000113	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ALB—lung cancer	1.16e-05	0.000113	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—RAF1—lung cancer	1.16e-05	0.000113	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—ERBB2—lung cancer	1.15e-05	0.000112	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MTOR—lung cancer	1.13e-05	0.00011	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3CB—lung cancer	1.13e-05	0.00011	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ENO1—lung cancer	1.13e-05	0.00011	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—KIT—lung cancer	1.12e-05	0.000109	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3CG—lung cancer	1.12e-05	0.000109	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APC—lung cancer	1.12e-05	0.000109	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—NRAS—lung cancer	1.12e-05	0.000109	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—EGF—lung cancer	1.11e-05	0.000108	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP1A1—lung cancer	1.11e-05	0.000108	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ERCC2—lung cancer	1.1e-05	0.000107	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CXCL8—lung cancer	1.09e-05	0.000106	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—HRAS—lung cancer	1.08e-05	0.000105	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—MAPK3—lung cancer	1.07e-05	0.000105	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—POMC—lung cancer	1.07e-05	0.000104	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—BRAF—lung cancer	1.05e-05	0.000103	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—AKT1—lung cancer	1.05e-05	0.000102	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CASP3—lung cancer	1.04e-05	0.000101	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IL6R—lung cancer	1.04e-05	0.000101	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—APOA1—lung cancer	1.04e-05	0.000101	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IL2—lung cancer	1.04e-05	0.000101	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CREBBP—lung cancer	1.04e-05	0.000101	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—IL6—lung cancer	1.04e-05	0.000101	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3CB—lung cancer	1.03e-05	0.0001	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—EGFR—lung cancer	1.02e-05	9.94e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PTGS2—lung cancer	1.02e-05	9.91e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP2E1—lung cancer	1.02e-05	9.88e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CCND1—lung cancer	1.01e-05	9.87e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—JUN—lung cancer	1.01e-05	9.85e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NQO1—lung cancer	1e-05	9.77e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	9.97e-06	9.7e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MAP2K1—lung cancer	9.93e-06	9.66e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3CD—lung cancer	9.87e-06	9.59e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MMP9—lung cancer	9.85e-06	9.58e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CDKN1A—lung cancer	9.82e-06	9.54e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PTEN—lung cancer	9.79e-06	9.52e-05	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—PIK3CA—lung cancer	9.77e-06	9.5e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—KRAS—lung cancer	9.66e-06	9.39e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—AKT1—lung cancer	9.56e-06	9.29e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3CG—lung cancer	9.51e-06	9.25e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—APOA1—lung cancer	9.5e-06	9.23e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—EP300—lung cancer	9.34e-06	9.08e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	9.09e-06	8.84e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SRC—lung cancer	9.08e-06	8.83e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—STK11—lung cancer	9.06e-06	8.81e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—POMC—lung cancer	9.05e-06	8.8e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PTEN—lung cancer	8.89e-06	8.64e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PIK3CA—lung cancer	8.87e-06	8.63e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—VEGFA—lung cancer	8.85e-06	8.6e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MDM2—lung cancer	8.84e-06	8.59e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CREBBP—lung cancer	8.82e-06	8.57e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—RAF1—lung cancer	8.81e-06	8.56e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—STAT3—lung cancer	8.76e-06	8.52e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NRAS—lung cancer	8.74e-06	8.5e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ERBB2—lung cancer	8.71e-06	8.47e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3CG—lung cancer	8.67e-06	8.43e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3CB—lung cancer	8.6e-06	8.36e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MTOR—lung cancer	8.6e-06	8.36e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—EP300—lung cancer	8.48e-06	8.24e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GSTP1—lung cancer	8.38e-06	8.15e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MAPK3—lung cancer	8.37e-06	8.14e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3CD—lung cancer	8.36e-06	8.13e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CXCL8—lung cancer	8.26e-06	8.04e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—POMC—lung cancer	8.25e-06	8.02e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ALB—lung cancer	8.25e-06	8.02e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—HRAS—lung cancer	8.21e-06	7.98e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CAT—lung cancer	8.15e-06	7.93e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MYC—lung cancer	8.14e-06	7.91e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CREBBP—lung cancer	8.04e-06	7.82e-05	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—AKT1—lung cancer	7.98e-06	7.76e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—EGFR—lung cancer	7.96e-06	7.74e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ABCB1—lung cancer	7.93e-06	7.71e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CASP3—lung cancer	7.91e-06	7.69e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IL2—lung cancer	7.9e-06	7.68e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—IL6—lung cancer	7.86e-06	7.64e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—TYMS—lung cancer	7.79e-06	7.57e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GSTM1—lung cancer	7.7e-06	7.49e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCND1—lung cancer	7.7e-06	7.49e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—JUN—lung cancer	7.68e-06	7.47e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3CD—lung cancer	7.62e-06	7.41e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ALB—lung cancer	7.52e-06	7.32e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—KRAS—lung cancer	7.52e-06	7.31e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MMP9—lung cancer	7.47e-06	7.27e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CDKN1A—lung cancer	7.45e-06	7.24e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PTEN—lung cancer	7.43e-06	7.23e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP1A1—lung cancer	7.3e-06	7.1e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3CB—lung cancer	7.29e-06	7.08e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—AKT1—lung cancer	7.25e-06	7.05e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ERCC2—lung cancer	7.24e-06	7.04e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PTGS2—lung cancer	7.22e-06	7.02e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—EP300—lung cancer	7.09e-06	6.89e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3CA—lung cancer	6.91e-06	6.72e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SRC—lung cancer	6.89e-06	6.7e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—VEGFA—lung cancer	6.71e-06	6.53e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TP53—lung cancer	6.68e-06	6.5e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—STAT3—lung cancer	6.65e-06	6.46e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3CB—lung cancer	6.64e-06	6.46e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NRAS—lung cancer	6.63e-06	6.45e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PTGS2—lung cancer	6.58e-06	6.4e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—HRAS—lung cancer	6.39e-06	6.22e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MAPK3—lung cancer	6.35e-06	6.17e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PTEN—lung cancer	6.3e-06	6.12e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3CA—lung cancer	6.27e-06	6.1e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOA1—lung cancer	6.26e-06	6.09e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MYC—lung cancer	6.18e-06	6e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IL6—lung cancer	6.12e-06	5.95e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—EGFR—lung cancer	6.04e-06	5.87e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—EP300—lung cancer	6e-06	5.84e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PTEN—lung cancer	5.74e-06	5.58e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3CG—lung cancer	5.72e-06	5.56e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—KRAS—lung cancer	5.71e-06	5.55e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AKT1—lung cancer	5.64e-06	5.49e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—EP300—lung cancer	5.48e-06	5.32e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—POMC—lung cancer	5.44e-06	5.29e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CREBBP—lung cancer	5.3e-06	5.15e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3CA—lung cancer	5.24e-06	5.1e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—AKT1—lung cancer	5.12e-06	4.98e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TP53—lung cancer	5.07e-06	4.93e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3CD—lung cancer	5.03e-06	4.89e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALB—lung cancer	4.96e-06	4.82e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HRAS—lung cancer	4.85e-06	4.72e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IL6—lung cancer	4.64e-06	4.51e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3CA—lung cancer	4.44e-06	4.32e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3CB—lung cancer	4.38e-06	4.26e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PTGS2—lung cancer	4.34e-06	4.22e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AKT1—lung cancer	4.28e-06	4.16e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3CA—lung cancer	4.05e-06	3.94e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PTEN—lung cancer	3.79e-06	3.68e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—AKT1—lung cancer	3.63e-06	3.53e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—EP300—lung cancer	3.61e-06	3.51e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—AKT1—lung cancer	3.31e-06	3.22e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3CA—lung cancer	2.67e-06	2.6e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—AKT1—lung cancer	2.18e-06	2.12e-05	CbGpPWpGaD
